Noevir Holdings Co., Ltd. (4928)

Name: Noevir Holdings Co., Ltd. (4928) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Consumer Defensive · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs.

Cifras clave

Capitalización bursátil: JPY 152 billion
Ingresos (ejercicio cerrado en 2025-09-30): JPY 64.7B
Beneficio neto: JPY 8.0B
Margen bruto: 66.9%
Margen neto: 12.4%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Ingresos totales	JPY 64.7B	JPY 63.8B	JPY 62.6B	JPY 61.1B
Beneficio bruto	JPY 43.3B	JPY 43.2B	JPY 42.6B	JPY 42.1B
Ingresos operativos (EBIT)	JPY 11.1B	JPY 11.4B	JPY 11.0B	JPY 10.1B
Ingresos netos	JPY 8.0B	JPY 8.0B	JPY 7.7B	JPY 7.6B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 4928. /companies/us/4928

Empresas similares

7956 · Pigeon Corporation

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.